David Weill
Direktor/Vorstandsmitglied bei TRANSMEDICS GROUP, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von David Weill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TRANSMEDICS GROUP, INC. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Independent Dir/Board Member | 01.01.2019 | - | |
Weill Consulting Group | Corporate Officer/Principal | 01.01.2016 | - |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von David Weill
Ehemalige bekannte Positionen von David Weill
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Stanford University Medical Center | Corporate Officer/Principal | 01.01.2005 | 01.01.2016 |
Stanford Center For Advanced Lung Diseases | Direktor/Vorstandsmitglied | - | - |
Ausbildung von David Weill
Tulane University (Louisiana) | Undergraduate Degree |
Tulane University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRANSMEDICS GROUP, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Weill Consulting Group | |
Stanford Center For Advanced Lung Diseases | |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Health Technology |
Stanford University Medical Center |
- Börse
- Insiders
- David Weill
- Erfahrung